|
|||
|
Multiple Sclerosis Info
|
Friday, March 7
by
multiplesclerosis
on Fri 07 Mar 2008 07:04 AM CST
placebo-controlled study will assess the safety profiles of single and multiple oral doses in healthy volunteers.
"The effective treatment of multiple sclerosis remains a more »
by
multiplesclerosis
on Fri 07 Mar 2008 06:44 AM CST
the independent Data Safety Monitoring Board (DSMB) for the Company's phase II MINDSET-01 trial of MBP8298 in patients with relapsing-remitting MS has completed a safety analysis and recommended that the trial continue as more »
by
multiplesclerosis
on Fri 07 Mar 2008 01:00 AM CST
Lhermitte's sign, the occurrence of an electrical sensation passing down the back to the legs on flexion of the neck is a common and characteristic feature of multiple sclerosis (MS) which is related to spinal cord lesions affecting more »
by
multiplesclerosis
on Fri 07 Mar 2008 12:00 AM CST
SRT501, when orally administered, slows retinal ganglion cell loss during optic neuritis more »
|
||